Read the full press release here. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug development. These tools will allow researchers to better […]
Read the full press release from BusinessWire here. TAI Diagnostics Announces New Publication using the myTAIHEART® Test in The Journal of Heart and Lung Transplantation TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication of “Donor Fraction Cell-Free DNA and Rejection in Adult and […]
Read the full press release from BusinessWire here. Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which was expanded to $4 million due to […]
Read the full press release from Promentis Pharmaceuticals here. Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced it has successfully completed a behavioral biomarker study for its lead compound, SXC-2023, and has finished enrolling patients in a Phase 2 multi-center study in its first indication, trichotillomania. Promentis is developing […]
Read the full press release on BusinessWire here. TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication, “Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA” in the October, 2019 issue of The Journal of Heart and Lung Transplantation. The clinical study presented in the paper was […]
Read the full press release here. SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) has accepted SHINE’s Operating License Application to operate its medical isotope production facility in Janesville, Wis. The NRC’s acceptance confirms that SHINE’s application was complete and of sufficient quality for the NRC to start its detailed […]
Read the full press release here. Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced the launch of its new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster testing results to clients. Alcami invested in the Milliflex® Rapid System for the rapid sterility […]
Read the full press release from Business Wire here. SHINE Medical Technologies LLC today announced the closing of a $50-million financing with funds managed by Oaktree Capital Management L.P. (“Oaktree”), a leading global investment firm with more than $120 billion under management as of June 30, 2019. The financing supports the ongoing construction of SHINE’s […]
Read the full press release from Cellular Logistics here. UW-Madison physician researchers Amish Raval, M.D., and Tim Kamp, M.D., Ph.D., have been awarded a U01 Research Project Cooperative Agreement by The National Institutes of Health. Cellular Logistics, a UW spinout co-founded by Dr. Raval that is creating a new way to treat heart damage, and […]
Read the full article from Business Wire today. GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Critical Care Suite, an industry-first collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. Built in collaboration with UC San Francisco (UCSF), using GE Healthcare’s Edison platform, the AI algorithms help to […]